Back to Search Start Over

RIPK1 inhibition enhances the therapeutic efficacy of chidamide in FLT3-ITD positive AML, both in vitro and in vivo

Authors :
Jun Li
Dan Liao
Fujue Wang
Zhongwang Wang
Yueshan Li
Yu Xiong
Ting Niu
Source :
Leukemia & Lymphoma. 63:1167-1179
Publication Year :
2021
Publisher :
Informa UK Limited, 2021.

Subjects

Subjects :
Cancer Research
Oncology
Hematology

Details

ISSN :
10292403 and 10428194
Volume :
63
Database :
OpenAIRE
Journal :
Leukemia & Lymphoma
Accession number :
edsair.doi...........a79824bc16797edf36b6bf3cf691460e

Tools

Authors Abstract Subjects Details